What is the ROE (Return on Equity) of BioCorRx this year?
The ROE of BioCorRx this year is 0.38 undefined.
BioCorRx ROE 2024
BioCorRx ROE
0.38
Ticker
BICX
ISIN
US09073C2052
WKN
A1XERB
In 2024, BioCorRx's return on equity (ROE) was 0.38, a -29.1% increase from the 0.54 ROE in the previous year.
BioCorRx Aktienanalyse
What does BioCorRx do?
The company BioCorRx Inc is a US-American company that was founded in 2008 and is headquartered in Anaheim, California. BioCorRx specializes in the development and marketing of innovative treatment methods for alcohol and drug dependency. The history of BioCorRx began with the introduction of its flagship product, the BioCorRx Recovery Program, which is based on a novel medical technology called Naltrexone/Buprenorphine Implant. Unlike traditional methods of treating alcohol and drug addiction, which typically rely on medication and psychotherapeutic support, the BioCorRx Recovery Program is an implantable, long-term treatment system that continuously delivers the active ingredient Naltrexone or Buprenorphine into the patient's body. The idea behind this is that the active ingredients prevent withdrawal symptoms and thereby reduce the risk of relapse. In recent years, BioCorRx has expanded its product portfolio and expanded its business activities to new segments in order to further drive the company's growth. This includes, for example, the field of telemedicine services, which allow BioCorRx to offer its treatment technology and medical services through online communication. Telemedicine services such as virtual patient consultation or online group therapy programs are particularly in demand in times of COVID-19. Another focus of BioCorRx is the management of medical personnel. Studies have shown that good patient care and counseling heavily influence the success of treatment. BioCorRx has now also developed its own platform that eases and improves the management, training, and monitoring of medical staff. BioCorRx also utilizes the concept of franchise systems to market its products and services. The franchise system offers medical professionals and organizations working in the field of addiction treatment the opportunity to open their own BioCorRx clinic and offer the company's products and services in their local market. Each clinic is advised and supported by BioCorRx and must adhere to certain standards and quality criteria. In the future, BioCorRx plans to further diversify its product offering and develop new technologies to improve treatment options for alcohol and drug dependents. An example of such a technology is medication based on Ibogaine. BioCorRx has already started initial research in this direction and is actively working on pre-clinical studies. Overall, BioCorRx is a company that primarily focuses on innovative technologies for the treatment of addiction. The company has experienced substantial growth in recent years by expanding its product range and customer base, and focusing on the areas of telemedicine, personnel management, and franchise systems. With its forward-thinking technologies and strong emphasis on quality and patient satisfaction, BioCorRx is expected to continue playing an important role in addiction treatment in the years to come. BioCorRx ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding BioCorRx's Return on Equity (ROE)
BioCorRx's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing BioCorRx's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
BioCorRx's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in BioCorRx’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about BioCorRx stock
How has the Return on Equity (ROE) of BioCorRx developed compared to the previous year?
The ROE of BioCorRx has increased by -29.1% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of BioCorRx?
A high ROE indicates that BioCorRx generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of BioCorRx?
A low ROE can indicate that BioCorRx is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of BioCorRx affect the company?
A change in ROE (Return on Equity) of BioCorRx can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of BioCorRx?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of BioCorRx?
Some factors that can influence BioCorRx's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does BioCorRx pay?
Over the past 12 months, BioCorRx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioCorRx is expected to pay a dividend of 0 USD.
What is the dividend yield of BioCorRx?
The current dividend yield of BioCorRx is .
When does BioCorRx pay dividends?
BioCorRx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioCorRx?
BioCorRx paid dividends every year for the past 0 years.
What is the dividend of BioCorRx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is BioCorRx located?
BioCorRx is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioCorRx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioCorRx from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.
When did BioCorRx pay the last dividend?
The last dividend was paid out on 9/10/2024.
What was the dividend of BioCorRx in the year 2023?
In the year 2023, BioCorRx distributed 0 USD as dividends.
In which currency does BioCorRx pay out the dividend?
The dividends of BioCorRx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioCorRx
Our stock analysis for BioCorRx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioCorRx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
